Use Of Il-27 Antagonists To Treat Lupus

Abstract

This invention relates to methods of treating the autoimmune disorder lupus with IL- 27 antagonists, as well as articles of manufacture comprising IL- 27 antagonists. The invention also relates to methods and kits for identifying patients that are likely to respond to an IL-27 antagonist treatment.


Claims

Sign in to the Lens

Feedback